Exosome Therapy
Extracellular-Vesicle Infusions, The FDA 2019/2020 Safety Alert, Zero Approved Products, and the 'Next Big Thing' Pitch
Evidence grade 1 of 5, Untested. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- No FDA-approved exosome product; subject of FDA public safety alerts
Reference only. Not medical advice.
What can go wrong
Because exosome products are not manufactured under approved standards, documented harms include serious infections from contaminated preparations. Patients also bear high cost and the risk of forgoing evidence-based care. There is no controlled evidence of any benefit for ED, enlargement, or performance.
This is something to take to a clinician. The Atlas can tell you what is known about exosome therapy in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Exosomes are nanoscale extracellular vesicles secreted by cells (often derived from mesenchymal stem cells or placental tissue) that carry proteins, lipids, and RNA and are thought to mediate much of stem cells' paracrine signaling. Clinics market exosome injections and infusions as a cell-free 'next generation' regenerative therapy for ED and sexual performance. The regulatory reality is stark: there are no FDA-approved exosome products for any use, and the FDA issued a public safety notification in December 2019 (reiterated 2020) after multiple patients in Nebraska suffered serious adverse events from unapproved products marketed as containing exosomes. Exosomes used to treat disease are regulated as drugs and biologics requiring premarket approval. Disease claims for them are illegal, and evidence for ED specifically is nonexistent in controlled human trials.
Marketed as the successor to stem cells, with zero approved products and an FDA safety alert attached.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
How it is supposed to work
Exosomes are proposed to deliver the same paracrine cargo as stem cells, growth factors, cytokines, and regulatory RNAs, to promote angiogenesis and tissue repair without the risks of injecting live cells. The concept is scientifically active in research, but for sexual health there is no controlled human evidence, and commercial products are frequently uncharacterized, non-sterile, or mislabeled.
The catch: an unapproved biologic sold on a research buzzword
The FDA's position is unambiguous: exosome products intended to treat disease are drugs/biologics that require premarket review, and none is approved. The December 2019 safety notification warned that clinics deceive patients with unsubstantiated claims and cited serious adverse events (including a cluster of infections in Nebraska) from unapproved exosome products. Selling exosomes for ED therefore layers an unlawful disease claim on top of an unapproved, often poorly characterized biologic, with none of the controlled evidence the marketing implies.
What people get wrong
Often saidExosomes are the FDA-cleared upgrade to stem cells
ActuallyThere are zero FDA-approved exosome products for any use, and the FDA has issued a safety alert against unapproved ones.
Often saidExosome therapy regenerates erectile tissue
ActuallyThere is no controlled human evidence for ED. The claim is extrapolated from bench research.
Often saidIt's safe because it's 'just signaling molecules'
ActuallyUnapproved preparations have caused serious infections; they are not manufactured to approved standards.
Who profits, and who pushes back
US FDA
There are currently no FDA-approved exosome products; some patients have been seriously harmed by unapproved products marketed as containing exosomes.
Suppliers of exosome preparations and the clinics infusing them capture the revenue; because there is no approved product, the entire category operates outside the approval pathway it markets around.
What we do not know
- Can characterized, standardized exosome products ever be manufactured and tested to an approvable standard?
- Will enforcement extend to the sexual-health marketing of exosomes as it has to broader claims?
At a glance
- FDA-approved products
- Zero (any indication)
- FDA action
- Public safety notification, Dec 2019 (reiterated 2020)
- Regulatory class
- Drug / biologic requiring approval
- Controlled ED evidence
- None
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Exosome Therapy. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- Where we land. We have not taken a position on this yet.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
FDA Public Safety Notification on Exosome Products2019
No FDA-approved exosome products; multiple serious adverse events (Nebraska infection cluster) from unapproved products; disease claims are unsubstantiated